Regen BioPharma (RGBPP) Long-Term Debt Repayments (2023 - 2024)
Historic Long-Term Debt Repayments for Regen BioPharma (RGBPP) over the last 2 years, with Q4 2024 value amounting to $65799.0.
- Regen BioPharma's Long-Term Debt Repayments rose 24150.32% to $65799.0 in Q4 2024 from the same period last year, while for Dec 2025 it was $65799.0, marking a year-over-year decrease of 3567.97%. This contributed to the annual value of $194599.0 for FY2025, which is 204599.0% up from last year.
- According to the latest figures from Q4 2024, Regen BioPharma's Long-Term Debt Repayments is $65799.0, which was up 24150.32% from $36500.0 recorded in Q1 2024.
- In the past 5 years, Regen BioPharma's Long-Term Debt Repayments ranged from a high of $65799.0 in Q4 2024 and a low of -$46500.0 during Q4 2023